Recovery · peptide
BPC-157
Body Protection Compound 157
Also sold as: BPC157 · Body Protection Compound · PL 14736 · Bepecin · pentadecapeptide BPC 157
A synthetic 15-amino-acid peptide sold for laboratory research, with striking tissue-healing results in rodents and essentially no controlled human evidence.
What the evidence says
Graded on the compound profile, not restated here.
BPC-157
A synthetic 15-amino-acid peptide with striking tissue-healing effects in rodent studies — and essentially no controlled human evidence. Sold as a research chemical, not an approved drug.
- DPreclinicalTendon and ligament healingPromising in rats; not demonstrated in humans.
- DPreclinicalGut / GI protectionAnimal data only.
- DPreclinicalMuscle and soft-tissue recoveryPreclinical signal, no human confirmation.
- UUnknownAny long-term safety outcomeUnknown — no controlled human safety data exist.
BPC-157 is sold as a research chemical, not an approved drug. Nothing on this page is a recommendation to take it, and its evidence base is covered in full on the BPC-157 compound profile — the short version is that the tendon and gut results are real, reproduced, and in rats, with no controlled human trials behind them.
What this page covers is the part the evidence articles do not: if you are buying this anyway, what separates a supplier who can document what is in the vial from one who cannot.
What a COA has to show
The single most useful skill in this market is reading a certificate of analysis, because almost every quality question reduces to whether the vendor can produce one for your lot.
A COA that names a lot number matching your vial, reports HPLC purity with the chromatogram attached, confirms identity by mass spectrometry, and states net peptide content is doing its job. One that shows a purity percentage on a product page with no document behind it is marketing.
Identity matters more than purity, and it is the check most often skipped. A vial can be 99% pure and contain the wrong peptide.
What its regulatory status means for availability
FDA placed BPC-157 in category 2 of its interim compounding policies — bulk drug substances that may present significant safety risks — and its status has moved more than once since. That is why supply and legality shift: this is not a stable product category.
The compounded peptides article tracks where that stands.
Before you buy
- A COA that names the specific lot number printed on your vial — not a generic COA for the product line.
- HPLC purity with the chromatogram attached, not a bare '99%' figure on a web page.
- Mass-spec identity confirmation. Purity without identity tells you the vial is 99% something.
- Net peptide content, which is lower than vial weight once counterions and residual solvent are excluded.
- An independent lab named on the COA. A vendor's own assay is a self-report.
What is sold
- Forms
- 5 mg vial · 10 mg vial
- Typical price
- $40–$70 per 5 mg vial Indicative only. Not a live price.
- Storage
- Supplied lyophilized. Reconstituted vials are on a clock set by refrigeration, preservative, and peptide stability rather than by remaining doses.
Last reviewed 2026-08-24.